期刊文献+

代谢综合征在原发性醛固酮增多症中的患病特征 被引量:4

The clinical characateristics of the metabolic syndrome in patients with primary aidosteronism
下载PDF
导出
摘要 目的 通过分析62例原发性醛同酮增多症(原醛症)患者的临床资料,了解代谢综合征在原醛症患者中的发病及临床特征,并初步探讨醛固酮对代谢影响及可能的机制.方法 收集62例原醛症患者和60例年龄和体质指数相匹配的原发性高血压患者的临床资料.结果 1.原醛症患者中代谢综合征的患病率高于原发性高血压对照组,且在代谢综合征中除高血压和肥胖外、血脂异常和糖调节异常的患病率也高于对照组.2.相关分析显示卧位血浆醛固酮水平与体质指数、腰围、血钾及尿钾水平明显负相关,立位醛同酮水平与体质指数显著负相关,醛同酮/肾素比值与总胆同醇、低密度脂蛋门胆固醇水平明显负相关.结论 1.原醛症与代谢综合征密切相关,其血糖和血脂异常表现尤其突出;2.醛固酮对糖脂代谢的影响与肾素活性有关,血浆醛周酮/肾素比值较血浆醛固酮水平能更好反映醛固酬对代谢的影响. Objective To assess the characteristics of the metabolic syndrome(MS) in patients with primary aldosteronism by analyzing the clinical information of 62 patients with primary aldosteronism (PA) ,and to explore the possible mechanism of the effects of aldosterone on the metabolism. Methods We analysed all the 62 patients with PA,60 patients with essential hypertension(EH). Results 1. The prevalence of MS in PA group was higher than in EH group,distribution of single components of the metabolic syndrome other than hypertension and obesity showed a higher prevalence of hypertriglyeerids,lowering high-density lipoprotein cholesterol(HDL-C) and hyperglycemia in PA than in EH. 2. The correlation study show that aldosterone was associated with BMl,plasma and uremia potassium. The aldosterone renin ratio was associated with TC and LDL-C. Conclusions 1. The primary aldosteronism was closely associated with metabolic syndrome, and the metabolic abnormalities including hyperglycemia and dyslipidemia was more common in patients with PA. 2. The effects of aldosterone on the metabolinism was associated with the activity of the rennin,and the aldosterone renin ratio was better than the plasma aldosterone level to reflect the effects on metabolism..
出处 《临床内科杂志》 CAS 2011年第2期107-109,共3页 Journal of Clinical Internal Medicine
关键词 代谢综合征 原发性醛固酮增多症 Primary aldosteronism Essential hypertension
  • 相关文献

参考文献14

  • 1Seifarth C, Trenkel S, Schobel H, et al. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism. Eur J Endocrino1,2004,150:329-337.
  • 2Bochud M, Nussberger J, Bovet P, et al. Plasma aldosterone is indenpendently associated with the metabolic syndrome. Hypertension ,2006, 48:239-245.
  • 3Franeesco F, Giovanni F, Franco V, et al. The metabolic syndrome in primary aldosteronism. Curr Hypertens Rep ,2007,9 : 106-111.
  • 4Gilberta G, Vanessa R, Federica T, et al. Aldosterone as a key mediator of the eardiometabolie syndrome in primary aldosteronism:an observa- tional study. J Hypertens,2007,25 : 177-186.
  • 5Krug AW,Ehrbart-Bornstein M. Aldosterone and Metabolic syndrome is increased aldosterone in metabolic syndrome patients an additional risk factor? Hypertension ,2008,51 : 1252-1258.
  • 6Perkins JM,Davis SN. The renin-angiotensin-aldosterone system:a pivotal role in insulin sensitivity and glycemic control. Curr Opin Endocri- nol Diabetes Obes,2008,15 : 147-152.
  • 7Mossn LM, Carvajal CA, Maiz A, et al. A possible association between priming, aldosteronism and a lower beta-cell ruction. J Hypertens,2007, 25:2125-2130.
  • 8Giacchetti G, Sechi LA, Rilli S, et rune system, glucose metabolism Metab, 2005, 1 6 : 120 - 125.
  • 9al. The rennin-angiotensin-aldosteand diabetes. Trends Endocrinol Bochud M, Nussberger J, Borer P, et al. Plasma aldosterone is independently associated with the metabolic syndrome. Hypertension ,2006, 48 : 239-245.
  • 10Dahlof B, Devereux RB, Kjeldsen SE, et al. Cadiovascular morbidity and mortality in the Losartan lntmwention For Endpoint reduction in hyper- tension study (LIFE) :a randomized trail against atenolol. Lancet, 2002, 359:995-1003.

同被引文献26

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部